Skip to content

Non-blanching rashes


Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp

One of my first experiences of clinical research was in my first PEM job (depressingly, in the last century). This was work in what became known locally as ‘The Spotty Rash’ trial. A child would present with a non-blanching rash, I would heave a deep sigh and go and assess them before measuring EVERY SINGLE spot on their body and then documenting EVERY SINGLE spot on a body map.

They then had bloods taken but I was left to decide whether the child needed antibiotics and admission or not. I and my fellow minions did this for a year (hence the deep sighing) and from this data and the data of many others an algorithm was produced –

The Newcastle-Birmingham-Liverpool (NBL) algorithm (which can be found here)

Later on NICE produced their own guidance in the form of clinical guideline CG102.

However, these algorithms and guidelines were produced over 10 years ago now. Are they still valid and is one guideline more sensitive and specific than another? These were the questions looked at recently by Riordan et al, and summarised below:


About the authors

  • Ian is a Paediatric Emergency Medicine Consultant based in Derby. He loves #FOAMed, Apple products, Comics, running and his family. In that order. He dislikes cauliflower cheese.


High flow therapy – when and how?

Chest compressions in traumatic cardiac arrest

Searching for sepsis

The missing link? Children and transmission of SARS-CoV-2

Don’t Forget the Brain Busters – Round 2

An evidence summary of Paediatric COVID-19 literature


The fidget spinner craze – the good, the bad and the ugly

Parenteral Nutrition

Leave a Reply

Your email address will not be published.



We use cookies to give you the best online experience and enable us to deliver the DFTB content you want to see. For more information, read our full privacy policy here.